Professor Tore Bengtsson, Ph.D.
Co-Founder & Chief Scientific Officer
Professor Bengtsson is the Co-Founder and Chief Scientific Officer of Sigrid Therapeutics AB. He is specialised in physiology and molecular biosciences at Stockholm University, leading an international group of experts in metabolism, obesity and its related diseases in the Department of Molecular Biosciences, the Wenner-Gren Institute (MBW).
Professor Bengtsson has broad experience from commercialising scientific research and delivering solutions to solve real world problems. He has been involved in a number of projects with Big Pharma and several successful startups, including Glucox Biotechnology AB and Symcel AB. Devoted to the Stockholm University research institution, Professor Bengtsson is the Board Member of Department of Molecular Biosciences, the Wenner-Gren Institute, the Biological Institute for Basic Education, Stockholm University Holding Company and Stockholm University Company Incubator.
Professor Bengtsson received his Ph.D. in Physiology from Stockholm University, Sweden.